Top Cost-Containment Stories
Eli Lilly to acquire three vaccine developers for nearly $4B
By Alan GoforthThe acquisitions of Cuerevo, LimmaTech Biologics and Vaccine Company will expand Eli Lilly's research and development efforts in infectious diseases.







